매 달의 보관소: October 2009

Industry Years Behind on Testing Approved Drugs

WASHINGTON — Federal drug officials have long been criticized for failing to force drug makers to complete studies proving that their drugs work as hoped, and Congressional investigators on Monday released yet another report pointing out that some of these

전세계 에 올린 글

Efficacy of dapsone in the treatment of pemphigus and pemphigoid: analysis of current data.

Dapsone is a chemotherapeutic agent primarily used in treating leprosy, Pneumocystis jiroveci (previously carinii) pneumonia, and malaria. It is also used as an adjuvant in the treatment of pemphigus and pemphigoid.

전세계 에 올린 글

Patients protest losing drug coverage

ALBUQUERQUE (KRQE) – A group of New Mexicans is protesting changes by Presbyterian Health Plan that now deny them a drug they say was effective in fighting their rare disease.

전세계 에 올린 글

Stimulus funds boost electronic health records

The national health care debate continues on Capitol Hill, but that won’t stop Springfield medical leaders from injecting innovation into the local health care scene.

전세계 에 올린 글

Virus Is Found in Many With Chronic Fatigue Syndrome

Many people with chronic fatigue syndrome are infected with a little known virus that may cause or at least contribute to their illness, researchers are reporting.

전세계 에 올린 글

A New Web Tool to Take Control of Your Health

The national health care debate right now is all about giving more people affordable access to doctors and hospitals. Yet the vast majority of health care decisions — 80 percent or more, experts say — are really made by individuals,

전세계 에 올린 글

Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study

Bullous pemphigoid (BP), pemphigus vulgaris (PV) and pemphigus foliaceus (PF) are autoimmune bullous diseases characterized by the presence of tissue-bound and circulating autoantibodies directed against disease-specific target antigens of the skin. Although rare, these diseases run a chronic course and

전세계 에 올린 글

오늘 가입!

P/P 레지스트리 서쪽 기관 검토 위원회에 의해 승인 되었습니다. (WIRB) 그리고 적극적으로 등록 하는 참가자는.

영어 버전

스페인어 버전